Medical Decision Alliance
Key Facts
| Invested since | 2025 |
| Based in | Saxony |
About the company
Medical Decision Alliance
MDA was founded in 2023 by Dr Gunter Trojandt, Annett Christ and two business angels, Jozsef Bugovics and Nils Kröber. MDA has a total of 10 employees and is based in Leipzig, Germany. The founding team has been working together for more than 10 years and successfully sold their last joint company, SPI – Surgical Process Institute, to Johnson & Johnson – a leading global manufacturer of medical devices and surgical robots – in 2017.
The focus of SPI and MDA is on the operating room and improving the quality of patient outcomes. All developments are carried out in close collaboration with leading physicians, clinics and medical device companies.
With the capital from the current round of financing, MDA will double the size of its team, recruit additional clinics (knowledge providers) and medical device companies (collaborators), and develop AI-based surgical training and assistance solutions.
Do you want to
know more about this company?
Medical Decision Alliance in the news
Zum Artikel
MDA – Medical Decision Alliance secures €3.3 million in seed funding to develop comprehensive surgical support systems
More startups from Life Sciences
DNTOX GmbH was founded in March 2022 as a spin-off from the IUF – Leibniz Institute for Environmental Medicine Research and is based on the longstanding research work of Professor …
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, is pioneering computational pathology for pharmaceutical research and diagnostics. Its proprietary “Explainable AI” platform draws on …
SIRION BIOTECH produces genetically modified cells and is technology provider in the area of viral vector systems. The specialist in RNAi technology distributes more than 100 products and services. A …
Humedics markets a system for bedside and instantaneous measurement of liver function. Patented device, consumables and a diagnostic drug allow an optimal market offering.
PreComb Therapeutics AG is a privately held Swiss biotech company founded in 2018 by Jens M. Kelm, Peter Steiner and Olivier Mauti with the aim of developing technologies that bring …
Amedrix develops & produces three dimensional implants (gel and liquid) based on collagen. Focus: treatment of articular cartilage damage in human an horse and other promising application areas. CE-mark for …
adivo is a biotech company generating therapeutic antibodies for companion animals, addressing the medical needs in dogs, with an upside potential for a future in care for other species. Antibody …
Signatope develops the next generation of protein biomarker assays using a novel type of mass spectrometry-based immunoassays. SIGNATOPE (SIGNAture epiTOPE) immunoassays are capable of detecting and quantifying protein biomarkers in …
WISE Srl is a Milan and Berlin-based company developing genuinely novel and minimally-invasive implantable leads for Neuromodulation and Neuromonitoring: highly conformable, stretchable, unbreakable and cheaper to produce.
Treatment of sustainable plaque in coronary arteries through our proprietary catheter based device.
Intelligent fluids GmbH is designing innovative high performance cleaning fluids for industrial application that are unique in the world. These intelligent fluids® are based on a groundbreaking, patented technology that …
